A recent report published by Infinium Global Research on
patient blood management market provides in-depth analysis of segments and
sub-segments in the global as well as regional patient blood management market.
The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional patient blood management market over the
short term as well as long term. The report is a comprehensive presentation of
trends, forecast and dollar values of global patient blood management market.
According to the report, the global patient blood management market is
projected to grow at a CAGR of 7.3% over the forecast period of 2019-2025.
Patient blood management is a multidisciplinary approach to
optimize the care of patients that need a transfusion. It includes all aspects
of patient evaluation and clinical management associated with the transfusion
decision making process. This system ensures that the blood components are
available for the patients that need them.
The rising demand for donated blood will augment the growth
of the patient blood management market. Various medical surgical procedures
require donated blood. Additionally, a growing number of trauma cases and a
surge in the number of road accidents stimulate the expansion of the patient
blood management market. A study estimated that road accidents claim the lives
of 1.3 million people every year worldwide. Further, medical-surgical
procedures need blood transfusions to make up for blood loss incurred during
the procedures. The increasing number of surgical procedures contributes to the
expansion of the patient blood management market. According to the World Health
Organization, the global surgical rate is nearly 4469 operations per 100000
people every year. The growing number of blood donations and blood donors led
to the expansion of the patient blood management market. As per the World
Health Organization, around 117.4 million blood donations collected globally.
In addition, the rising prevalence of blood disorders boosts the development of
the patient blood management market. A study estimated that in 2018 around 210
thousand people had haemophilia and 78 thousand people had von Willebrand
disease worldwide. On the other side, the high cost of automated systems
hampers the growth of the patient blood management market. Moreover, the
adoption of patient blood management systems in developing countries creates
several opportunities in the global patient blood management market.
Geographically, the global patient blood management market
is segmented into North America, Asia-Pacific, Europe, and the Rest of the
World. North America is expected to hold a premium share in the global patient
blood management market. The growing demand for blood and blood component for
treating different blood disorders and well-established healthcare
infrastructure in North America drive the expansion of patient blood management
market in North America. Asia-Pacific region has the fastest CAGR in the global
patient management market over the forecast period. The rising healthcare
expenditure in developing countries and growing healthcare infrastructure in
the Asia-Pacific region led to the growth of the patient blood management
market in Asia-Pacific. Europe has a significant share in the global patient
management market owing to the increasing aging population and the adoption of
technologically advanced products in the region. A study estimated that around
520 million people in the European Union will be aged over 65 by 2070.
The report on global patient blood management market covers
segments such as product, component, and end-user. On the basis of product, the
sub-markets include instruments, accessories, software, and reagents and kits.
On the basis of component, the sub-markets include plasma, and whole blood and
red blood cells. On the basis of end-user, the sub-markets include blood banks,
hospitals, and diagnostic clinics.
The report provides profiles of the companies in the market
such as B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., Kaneka
Corporation, Abbott Laboratories, F. Hoffmann-La Roche AG, Terumo Corporation,
LivaNova PLC, Danaher Corporation, Immucor, Inc., Macopharma, and Other
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of patient blood
management market. Moreover, the study highlights current market trends and
provides forecast from 2019-2025. We also have highlighted future trends in the
market that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.